Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Mori, Valerio ^a   Amici, Adolfo ^a   Mazzola, Francesca ^a   Di Stefano, Michele ^b   Conforti, Laura ^b   Magni, Giulio ^c   Ruggieri, Silverio ^a   Raffaelli, Nadia ^a   Orsomando, Giuseppe ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; GLUTAMIC ACID; GLUTAMINE; ISOENZYME; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; PHOSPHATE; POLYPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID ADENINE DINUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SUBSTRATE; ENZYME SYNTHESIS; HEART; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; SKELETAL MUSCLE; SMALL INTESTINE; SPLEEN; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; METABOLISM;

ANIMALS; MICE; MICE, INBRED C57BL; NAD; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE;

EID: 84912572145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113939     Document Type: Article

References (64)

1. Ueda K, Hayaishi O (1985) ADP-ribosylation. Annu Rev Biochem 54: 73-100.
2. Satoh A, Stein L, Imai S (2011) The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol 206: 125-162.
3. Clapper DL, Walseth TF, Dargie PJ, Lee HC (1987) Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphosphate. J Biol Chem 262: 9561-9568.
4. Imai S, Yoshino J (2013) The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metab 15: 26-33.
5. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324: 654-657.
6. Magni G, Orsomando G, Raffelli N, Ruggieri S (2008) Enzymology of mammalian NAD metabolism in health and disease. Front Biosci 13: 6135-6154.
7. Belenky P, Bogan KL, Brenner C (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32: 12-19.
8. Petrelli R, Felczak K, Cappellacci L (2011) NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications. Curr Med Chem 18: 1973-1992.
9. Cappellacci L, Petrelli R, Franchetti P, Vita P, Kusumanchi P, et al. (2011) Synthesis and biological activity of novel N6-substituted and 2, N6-disubstituted adenine ribo- and 3′-C-methyl-ribonucleosides as antitumor agents. Eur J Med Chem 46: 1499-1504.
10. Magni G, Di Stefano M, Orsomando G, Raffaelli N, Ruggieri S (2009) NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem 16: 1372-1390.
11. Di Stefano M, Conforti L (2013) Diversification of NAD biological role: the importance of location. Febs J 280: 4711-4728.
12. Chiarugi A, Dolle C, Felici R, Ziegler M (2012) The NAD metabolome - a key determinant of cancer cell biology. Nat Rev Cancer 12: 741-752.
13. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, et al. (2004) Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61: 19-34.
14. Preiss J, Handler P (1958) Biosynthesis of diphosphopyridine nucleotide. II. Enzymatic aspects. J Biol Chem 233: 493-500.
15. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, et al. (2004) Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem 11: 873-885.
16. Berger F, Lau C, Dahlmann M, Ziegler M (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280: 36334-36341.
17. Zhai RG, Rizzi M, Garavaglia S (2009) Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme. Cell Mol Life Sci 66: 2805-2818.
18. Orsomando G, Cialabrini L, Amici A, Mazzola F, Ruggieri S, et al. (2012) Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues. PLoS One 7: e53271.
19. Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, et al. (2007) Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. Biochemistry 46: 4912-4922.
20. De Ingeniis J, Kazanov MD, Shatalin K, Gelfand MS, Osterman AL, et al. (2012) Glutamine versus ammonia utilization in the NAD synthetase family. PLoS One 7: e39115.
21. Conforti L, Janeckova L, Wagner D, Mazzola F, Cialabrini L, et al. (2011) Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. Febs J 278: 2666-2679.
22. Bieganowski P, Pace HC, Brenner C (2003) Eukaryotic NAD+ synthetase Qns1 contains an essential, obligate intramolecular thiol glutamine amidotransferase domain related to nitrilase. J Biol Chem 278: 33049-33055.
23. Osterman AL, Begley TP (2007) A subsystems-based approach to the identification of drug targets in bacterial pathogens. Prog Drug Res 64: 133-170.
24. Gilley J, Adalbert R, Yu G, Coleman MP (2013) Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. J Neurosci 33: 13410-13424.
25. Stavrum AK, Heiland I, Schuster S, Puntervoll P, Ziegler M (2013) Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data. J Biol Chem 288: 34555-34566.
26. Falk MJ, Zhang Q, Nakamaru-Ogiso E, Kannabiran C, Fonseca-Kelly Z, et al. (2012) NMNAT1 mutations cause Leber congenital amaurosis. Nat Genet 44: 1040-1045.
27. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4: 1199-1206.
28. Evans C, Bogan KL, Song P, Burant CF, Kennedy RT, et al. (2010) NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity. BMC Chem Biol 10: 2.
29. Yamada K, Hara N, Shibata T, Osago H, Tsuchiya M (2006) The simultaneous measurement of nicotinamide adenine dinucleotide and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 352: 282-285.
30. Formentini L, Moroni F, Chiarugi A (2009) Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo. Biochem Pharmacol 77: 1612-1620.
31. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, et al. (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15: 838-847.
32. Gholson RK (1966) The pyridine nucleotide cycle. Nature 212: 933-935.
33. Collins PB, Chaykin S (1972) The management of nicotinamide and nicotinic acid in the mouse. J Biol Chem 247: 778-783.
34. Micheli V, Simmonds HA, Sestini S, Ricci C (1990) Importance of nicotinamide as an NAD precursor in the human erythrocyte. Arch Biochem Biophys 283: 40-45.
35. Imai S (2009) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des 15: 20-28.
36. Nikiforov A, Dolle C, Niere M, Ziegler M (2011) Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 286: 21767-21778.
37. Balducci E, Emanuelli M, Raffaelli N, Ruggieri S, Amici A, et al. (1995) Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem 228: 64-68.
38. Sorci L, Martynowski D, Rodionov DA, Eyobo Y, Zogaj X, et al. (2009) Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis. Proc Natl Acad Sci U S A 106: 3083-3088.
39. Yoza N, Akazaki I, Nakazato T, Ueda N, Kodama H, et al. (1991) High-performance liquid chromatographic determination of pyrophosphate in the presence of a 20,000-fold excess of orthophosphate. Anal Biochem 199: 279-285.
40. Flodgaard H, Fleron P (1974) Thermodynamic parameters for the hydrolysis of inorganic pyrophosphate at pH 7.4 as a function of (Mg2+), (K+), and ionic strength determined from equilibrium studies of the reaction. J Biol Chem 249: 3465-3474.
41. Graeff R, Lee HC (2002) A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity. Biochem J 361: 379-384.
42. Segel IH (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. New York: John Wiley & Son, Inc. 564, 715 p.
43. Zerez CR, Wong MD, Tanaka KR (1990) Partial purification and properties of nicotinamide adenine dinucleotide synthetase from human erythrocytes: evidence that enzyme activity is a sensitive indicator of lead exposure. Blood 75: 1576-1582.
44. Hara N, Yamada K, Terashima M, Osago H, Shimoyama M, et al. (2003) Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency. J Biol Chem 278: 10914-10921.
45. Micheli V, Sestini S, Rocchigiani M, Jacomelli G, Manzoni F, et al. (1999) Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes. Life Sci 64: 2479-2487.
46. Di Stefano M, Galassi L, Magni G (2010) Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells. Blood Cells Mol Dis 45: 33-39.
47. Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, et al. (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 276: 406-412.
48. Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, et al. (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278: 13503-13511.
49. Yalowitz JA, Xiao S, Biju MP, Antony AC, Cummings OW, et al. (2004) Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas. Biochem J 377: 317-326.
50. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, et al. (2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297: 835-840.
51. Williamson DH, Brosnan JT (1974) Concentrations of Metabolites in Animal Tisuues. In: Bergmeyer HU, , editor., Methods of Enzymatic Analysis. Academic Press, Inc: Verlag Chemie Weinheim. pp. 2267-2300.
52. Kornberg A (1950) Reversible enzymatic synthesis of diphosphopyridine nucleotide and inorganic pyrophosphate. J Biol Chem 182: 779-793.
53. Rizzi M, Bolognesi M, Coda A (1998) A novel deamido-NAD+-binding site revealed by the trapped NAD-adenylate intermediate in the NAD+ synthetase structure. Structure 6: 1129-1140.
54. Frey PA, Arabshahi A (1995) Standard free energy change for the hydrolysis of the alpha, beta-phosphoanhydride bridge in ATP. Biochemistry 34: 11307-11310.
55. Rechsteiner M, Hillyard D, Olivera BM (1976) Magnitude and significance of NAD turnover in human cell line D98/AH2. Nature 259: 695-696.
56. Williamson DH, Lund P, Krebs HA (1967) The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103: 514-527.
57. Stubbs M, Veech RL, Krebs HA (1972) Control of the redox state of the nicotinamide-adenine dinucleotide couple in rat liver cytoplasm. Biochem J 126: 59-65.
58. Milde S, Gilley J, Coleman MP (2013) Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. PLoS Biol 11: e1001539.
59. Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, et al. (2014) Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 6: 721-731.
60. Goody MF, Kelly MW, Lessard KN, Khalil A, Henry CA (2010) Nrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis. Dev Biol 344: 809-826.
61. Shibata K, Morita N, Shibata Y, Fukuwatari T (2013) Enzymes that control the conversion of L-tryptophan-nicotinamide and the urinary excretion ratio (N(1)-methyl-2-pyridone-5-carboxamide + N(1)-methyl-4-pyridone-3-carboxamide)/N(1)-methylnicotinamide in mice. Biosci Biotechnol Biochem 77: 2105-2111.
62. Hikosaka K, Ikutani M, Shito M, Kazuma K, Gulshan M, et al . (2014) Deficiency of Nicotinamide Mononucleotide Adenylyltransferase 3 (Nmnat3) Causes Hemolytic Anemia by Altering the Glycolytic Flow in Mature Erythrocytes. J Biol Chem 289: 14796-14811.
63. Sestini S, Ricci C, Micheli V, Pompucci G (1993) Nicotinamide mononucleotide adenylyltransferase activity in human erythrocytes. Arch Biochem Biophys 302: 206-211.
64. Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. Febs J 279: 1356-1365.